Prostate cancer is a cancerous tumor of the thyroid gland. It’s relatively rare in comparison to other cancers. In the USA, it’s projected that in 2016 roughly 64,000 new patients will be diagnosed with thyroid cancer, in comparison to over 240,000 patients having breast cancer and 135,000 patients with colon cancer.
THERE ARE FOUR Kinds of THYROID CANCER:
- The papillary thyroid gland has become the most frequent kind of thyroid gland. Papillary thyroid cancer may happen at any age. It tends to grow gradually and spread into lymph nodes in the throat, and normally has a superb outlook. Follicular thyroid cancer may spread into lymph nodes in the throat but is much more inclined than papillary cancer to spread to remote organs, especially the bones and lungs.
- Medullary thyroid gland accounts for roughly 2 percent of all thyroid gland. Roughly 25 percent of medullary thyroid cancer is inherited, and also a test for a genetic mutation in the RET proto-oncogene may result in an early identification and, consequently, to healing surgery.
- The anaplastic thyroid gland has become the most innovative and aggressive thyroid gland. Anaplastic thyroid cancer is quite rare and can be found in less than 2 percent of individuals with the thyroid gland. It most commonly occurs in people over age 60 decades. The data in this booklet pertains to the Anaplastic thyroid gland.
The anaplastic thyroid gland is among the quickest growing and most competitive of all cancers. It’s also called undifferentiated thyroid cancer since the cells don’t behave or look at normal thyroid cells. The reason for anaplastic thyroid cancer is unknown, however, sometimes it originates in the environment of differentiated thyroid gland like papillary or follicular thyroid gland. While overall survival figures are discouraging — having a mean survival rate of 6 weeks and about 1 in 5 living after 12 weeks — it’s essential to be aware there are long-term survivors.